Renin–angiotensin–aldosterone system blockers and region-specific variations in COVID-19 outcomes: findings from a systematic review and meta-analysis

BACKGROUND AND AIMS: : Coronavirus disease 2019 (COVID-19) has been observed to cause a high mortality in people with cardiometabolic diseases. Renin–angiotensin–aldosterone system (RAAS) blockers enhance the expression of ACE2, the binding receptor of SARS-CoV-2, and can enhance viral infectivity....

Descripción completa

Detalles Bibliográficos
Autores principales: Kaur, Upinder, Chakrabarti, Sankha Shubhra, Patel, Tejas K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127587/
https://www.ncbi.nlm.nih.gov/pubmed/34035891
http://dx.doi.org/10.1177/20420986211011345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127587/
https://www.ncbi.nlm.nih.gov/pubmed/34035891
http://dx.doi.org/10.1177/20420986211011345

Ejemplares similares